跳至主要内容
临床试验/TCTR20211102002
TCTR20211102002招募中3 期

Efficacy of Aloe vera capsule versus omeprazole in the 4 weeks treatment of symptomatic gastroesophageal reflux disease

Dhurakij Pundit University0 个研究点目标入组 40 人开始时间: 2021年11月2日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • 1. Age 18-65 year
  • 2. Patient who was previously diagnosed with GERD or newly diagnosed at out patient department
  • 3. Must have heartburn symptom
  • 4. No history allergy to aloe vera or omeprazole
  • 5. Free from GERD treatment for 3 days prior

排除标准

  • Pre-randomization exclusion criteria
  • 1. During pregnancy or lactation
  • 2. Other gastrointestinal problem such as peptic ulcer, obstructive disease, irritable bowel syndrome
  • 3. Alarm features including gastrointestinal bleeding, anemia, involuntary weight loss) , recurrent vomiting, odynophagia
  • 4. Liver disease
  • 5. End stage renal disease
  • Post-randomization exclusion criteria
  • 1. Cannot tolerate side effect of aloe vera or omeprazole
  • 2. Not follow the protocol
  • 3. Use other drug or herb to treat GERD
  • 4. Pregnancy after enrollment
  • 5. Health or psychological harm
  • 6. Participate decided to withdraw
  • 7. Loss follow up at 2 or 4 weeks

研究者

相似试验